DHSC gives go ahead for boys to receive HPV vaccine

DHSC gives go ahead for boys to receive HPV vaccine

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect...

Home Office gives go ahead to allow cannabis-derived products on prescription

Home Office gives go ahead to allow cannabis-derived products on prescription

July 27 2018 Certain cannabis-derived products will be reclassified as Class 2 medicinal...

New law strengthens punishment for assaulting health sector workers

New law strengthens punishment for assaulting health sector workers

July 27 2018 A new law will increase the possible sentencing of someone who commits common...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

  • DHSC gives go ahead for boys to receive HPV vaccine

    DHSC gives go ahead for boys to receive HPV vaccine

    Friday, 27 July 2018 16:22
  • Home Office gives go ahead to allow cannabis-derived products on prescription

    Home Office gives go ahead to allow cannabis-derived products on prescription

    Friday, 27 July 2018 16:19
  • New law strengthens punishment for assaulting health sector workers

    New law strengthens punishment for assaulting health sector workers

    Friday, 27 July 2018 16:16
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:29
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 13:07

a alert imageApril 20 2018

A Class 4 medicines defect alert has been issued relating to Inhixa (enoxaparin sodium) solution for injection, made by Techdow Europe AB.

The medicines regulator, the MHRA, has issued the ‘caution in use’ alert following reports of “rare cases of premature self-activation of the safety device in unused, unopened pre-filled Inhixa syringes.”

The alert lists the following strengths of Inhixa:

  • 2,000 IU (20 mg) in 0.2 mL;
  • 4,000 IU (40 mg) in 0.4 mL;
  • 6,000 IU (60 mg) in 0.6 mL;
  • 8,000 IU (80 mg) in 0.8 mL;
  • 10,000 IU (100 mg) in 1.0 mL.

Pharmacy and GP dispensing practice staff have been asked to visually check all Inhixa syringes (without opening the syringe blister) before dispensing. This is illustrated on the Direct Healthcare Professional Communication (DHCP). 

Further information is available from Techdow Pharma England Ltd on 01271 334 609.

Link:
MHRA statement          
Techdow Direct Healthcare Professional Communication             

Professional News

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect them from cancer, the Department of Health and Social Care has announced.
July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...